Reagent for research, diagnostic tool. BORIS protein has been identified as Cancer-Testis Antigen (CTA) with testis-specific paralogue of the CCCTC-binding factor. Recent studies have demonstrated that d BORIS is directly responsible for the transcriptional activation of TSP50 (testes-specific protease 50).
| Inventor | Institute |
|---|---|
| Elena Klenova | University of Essex |
| SKU: | 152812 |
|---|---|
| Product description: | Reagent for research, diagnostic tool. BORIS protein has been identified as Cancer-Testis Antigen (CTA) with testis-specific paralogue of the CCCTC-binding factor. Recent studies have demonstrated that d BORIS is directly responsible for the transcriptional activation of TSP50 (testes-specific protease 50). |
| Alternate name: | Brother of the regulator of imprinted sites, Cancer/testis antigen 27, CCCTC binding factor (zinc finger protein) like, CCCTC-binding factor, CT27, CTCF paralog, CTCF T, CTCF-like protein, Ctcfl, CTCFL_HUMAN, dJ579F2.2, HMG 1L1, HMGB1L1, MGC163358, MGC16915, MGC16916 |
| Conjugation: | Unconjugated |
| Isotype: | IgG3 kappa |
| Molecular weight: | 83 kDa |
| Immunogen: | Synthetic peptide within the BORIS C-terminal domain (aa 614-648) (CG)GEMFPVACRETTARVKEE (NB – the first two aa do not belong to BORIS) |
| Cat. #: | 152812 |
|---|---|
| Provenance and Ownership: | The Anti-BORIS [20B11] mAb is owned by Cancer Research UK. CancerTools supplies the Anti-BORIS [20B11] mAb under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-BORIS [20B11] mAb directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Genetics |
| Application: | ChIP ; ELISA ; IHC ; IF ; IP ; WB |
| Target: | BORIS |
| Reactivity: | Human |
| Clone: | 20B11 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | BORIS protein has been identified as Cancer-Testis Antigen (CTA) with testis-specific paralogue of the CCCTC-binding factor. Recent studies have demonstrated that d BORIS is directly responsible for the transcriptional activation of TSP50 (testes-specific protease 50). |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Debruyne et al. 2019. Nature. 572(7771):676-680. PMID: 31391581. |
|---|
Monoclonal anti- BORIS C-terminal antibody from clone 20B11 specifically recognises the C terminal domain of BORIS; and the endogenous and exogenous BORIS protein. Cell lysates were resolved by SDS-PAGE; blotted and probed with the original mouse supernatant of the 20B11 clone. Positions of BORIS and the C-terminal domain of BORIS are indicated. B; bacterially expressed BORIS; *; 293T cells transfected with 0.5?g of the plasmid expressing BORIS; M; Molecular marker.

| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.